ABO and Parkinson disease: However, our data allow us to conclude that not any protein that is introduced into the CSF will impact the ChP to the same extent but that different disease-specific proteins known to be present in the CSF of patients (e.g., AβO in case of AD patients or α-syn in case of PD patients) may cause similar effects.